Multiple versus single arterial grafting in the elderly: a meta-analysis of randomized controlled trials and propensity score studies

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2022

Autores

Saraiva, FA (Autor) Outra; Moreira, R (Autor) Outra; Cerqueira, RJ (Autor) FMUP; Mancio, J (Autor) FMUP; Barros, AS (Autor) FMUP; Andre P Lourenco (Autor) FMUP; Leite-Moreira AF (Autor) FMUP

Revista

Título: Journal of Cardiovascular Surgery

Vol. 63

Páginas: 169-178

ISSN: 0021-9509

Editora: EDIZIONI MINERVA MEDICA

Indexação

ISI Web of Knowledge - 4 Citações

Scopus - 4 Citações

Outras Informações

ID Authenticus: P-00V-5N2

DOI: 10.23736/s0021-9509.21.11826-9

Abstract (EN): INTRODUCTION: The benefit of adding a second arterial conduit is still controversial, mainly in specific subgroups. We conducted a meta-analysis of randomized controlled trials (RCTs) and propensity score (PS) studies comparing survival and early results in elderly patients who underwent coronary' artery bypass grafting (CABG) with multiple (MAG) versus single arterial grafting (SAG). EVIDENCE ACQUISITION: MEDLINE, Web of Science and Cochrane Library were used to find relevant literature (1960-April 2020). Survival at a >= 1-year follow-up and early outcomes were evaluated. Outcomes were collected from matched samples or PS adjusted analysis: hazard ratio (HR) along with their variance, frequencies or odds ratios. Random effect models were used to compute combined statistical measures and 95% confidence intervals (CI) through generic inverse variance method (time-to-event) or Mantel-Haenszel method (binary events). EVIDENCE SYNTHESIS: Eleven PS cohorts and 1 RCT comprising >18,800 patients older than 70 (>6200 MAG and >12,500 SAG) were included in this meta-analysis. MAG was associated with lower long-term mortality (pooled HR: 0.81, 95% CI: 0.72-0.91, P<0.01, I-2 =64%) in the absence of higher risk of early mortality (pooled OR: 0.74, 95% CI: 044 to 1.25, P=0.27, I-2 =0%). In a meta-regression. MAG survival advantage was more pronounced in studies with a higher MAG usage rate (beta=-0.0052, P=0.021). CONCLUSIONS: Current evidence suggests that advanced age should not limit MAG's use considering its benefits in lona-term survival. Of note, an individualized patient selection for this approach is warranted.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 10